US FDA approves remdesivir for hospitalised COVID-19 patients, Goldman's fine over 1MDB largest ever in a corruption case, China's feeder ETFs

Michelle Martin and Ryan Huang discuss Gilead's remdesivir's approval by the US FDA for hospitalised COVID-19 patients, the US economy and COVID-19 in early minutes of the final presidential debate, Goldman facing the largest ever fine in a corruption case in the US and Singapore's fine of 165 million Singapore dollars over 1MDB, China's feeder ETFs available to overseas investors and early trading for the STI.  

See omnystudio.com/listener for privacy information.